2018

1. All-oral direct-acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real-world practice: Madrid coinfection registry findings

   Hepatology, Vol. 68, Núm. 1, pp. 32-47